Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated levels of serum alpha-2-macroglobulin associate with diabetes status and incident CVD in type 1 diabetes. | J Lipid Res | 2025 | 39761918 | PubTator, text mining | PubMed |
| Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease. | Nat Commun | 2025 | 39747090 | PubTator, text mining | PubMed |
| Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database. | Pediatr Nephrol | 2025 | 39729127 | PubTator, text mining | PubMed |
| Emerging role of genetics in kidney transplantation. | Kidney Int | 2025 | 39710162 | PubTator, text mining | PubMed |
| Surrogate Clinical End Points in Studies of APOL1-Associated Kidney Disease: Just in Time. | Clin J Am Soc Nephrol | 2025 | 39680444 | PubTator, text mining | PubMed |
| The Impact of Ancestry on Genome-Wide Association Studies. | Pac Symp Biocomput | 2025 | 39670375 | PubTator, text mining | PubMed |
| ApoL1 risk allele accelerates high-fat diet-induced atherosclerosis in LDLR-/- hamsters. | Genes Dis | 2025 | 39669548 | PubTator, text mining | PubMed |
Minimal Change Disease and Focal Segmental Glomerulosclerosis Are Associated with Good Kidney Prognosis and Thrombotic Microangiopathy with Poor Kidney Survival in Patients with COVID-19-Associated Nephropathies. | Am J Nephrol | 2025 | 39662073 | PubTator, text mining | PubMed |
| The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event. | G3 (Bethesda) | 2025 | 39658338 | PubTator, text mining | PubMed |
| Prevalence and Impact of APOL1 Kidney Risk Variants in West Africa : Insights for Global Kidney Disease Assessment and Treatment. | J Am Soc Nephrol | 2025 | 39602366 | PubTator, text mining | PubMed |
| Contribution of APOL1 variants to CKD risk in West Africans. | Nat Rev Nephrol | 2025 | 39592858 | PubTator, text mining | PubMed |
| Surrogate End Points in Apolipoprotein L1 - Associated Kidney Disease : Evaluation in Three Cohorts. | Clin J Am Soc Nephrol | 2025 | 39499577 | PubTator, text mining | PubMed |
| APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans. | N Engl J Med | 2025 | 39465900 | PubTator, text mining | PubMed |
| Epigenetic associations with kidney disease in individuals of African ancestry with APOL1 high-risk genotypes and HIV. | Nephrol Dial Transplant | 2025 | 39448372 | PubTator, text mining | PubMed |
| Sickle cell trait, APOL1 risk allele status and chronic kidney disease among ART-experienced adults living with HIV in northern Nigeria. | Int J STD AIDS | 2025 | 38915133 | PubTator, text mining | PubMed |
| Interferon Upregulation Associates with Insulin Resistance in Humans. | Curr Diabetes Rev | 2025 | 38500280 | PubTator, text mining | PubMed |
| Contribution of Apolipoprotein L1 (APOL1) Risk Alleles to Kidney Disease in West Africa: an opportunity for treatment. | Ghana Med J | 2024 | 40585512 | PubTator, text mining | PubMed |
| A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies. | Health Equity | 2024 | 40125376 | PubTator, text mining | PubMed |
| Cell-type deconvolution for bulk RNA-seq data using single-cell reference: a comparative analysis and recommendation guideline. | Brief Bioinform | 2024 | 39899596 | PubTator, text mining | PubMed |
| Analysis of Glomerular Transcriptomes from Nephrotic Patients Suggest APOL1 Risk Variants Impact Parietal Epithelial Cells. | medRxiv | 2024 | 39830251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=13